Australia markets closed

ProSomnus, Inc. (OSA)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.5301-0.0359 (-6.34%)
At close: 04:00PM EDT
0.5300 -0.00 (-0.02%)
After hours: 06:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.5660
Open0.5740
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.5300 - 0.5898
52-week range0.3450 - 5.2500
Volume9,011
Avg. volume64,679
Market cap9.221M
Beta (5Y monthly)0.21
PE ratio (TTM)N/A
EPS (TTM)-1.4900
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est2.50
  • Insider Monkey

    ProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call Transcript

    ProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call Transcript March 27, 2024 ProSomnus, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.31. OSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]

  • GlobeNewswire

    ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results

    PLEASANTON, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA), the leading non-CPAP therapy™ for the treatment of Obstructive Sleep Apnea (OSA), today announced financial results for the fourth quarter and year ended December 31, 2023. Recent Business Highlights Generated record revenues of $7.8 million for the fourth quarter and $27.7 million for the fiscal year 2023, a 35% increase compared to $5.8 million for the fourth quarter 2022 and 43% increase compared to $19.4 mi

  • GlobeNewswire

    ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

    PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced today it has postponed the release of its 2023 fourth quarter and full year financial results and the related investor conference call. The rescheduled call will be held after market close on Tuesday, March 26, 2024 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Registration and dial-in information can be found on the in